AU7663100A - Production of 5-substituted indolinones and use thereof as medicaments - Google Patents

Production of 5-substituted indolinones and use thereof as medicaments

Info

Publication number
AU7663100A
AU7663100A AU76631/00A AU7663100A AU7663100A AU 7663100 A AU7663100 A AU 7663100A AU 76631/00 A AU76631/00 A AU 76631/00A AU 7663100 A AU7663100 A AU 7663100A AU 7663100 A AU7663100 A AU 7663100A
Authority
AU
Australia
Prior art keywords
medicaments
production
substituted indolinones
indolinones
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76631/00A
Inventor
Armin Heckel
Jacobus Meel Van
Norbert Redemann
Gerald Jurgen Roth
Gisela Schnapp
Walter Spevak
Ulrike Tontsch-Grunt
Rainer Walter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharma GmbH and Co KG filed Critical BOEHRINGER INGELHEIM PHARMA
Publication of AU7663100A publication Critical patent/AU7663100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • C07F9/5728Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
AU76631/00A 1999-10-13 2000-10-07 Production of 5-substituted indolinones and use thereof as medicaments Abandoned AU7663100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19949209 1999-10-13
DE19949209A DE19949209A1 (en) 1999-10-13 1999-10-13 5-substituted indolinones, their preparation and their use as pharmaceuticals
PCT/EP2000/009847 WO2001027080A2 (en) 1999-10-13 2000-10-07 5-substituted indolinones and use thereof as kinase and cyclin/cdk complex inhibitors

Publications (1)

Publication Number Publication Date
AU7663100A true AU7663100A (en) 2001-04-23

Family

ID=7925398

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76631/00A Abandoned AU7663100A (en) 1999-10-13 2000-10-07 Production of 5-substituted indolinones and use thereof as medicaments

Country Status (6)

Country Link
EP (1) EP1224169A2 (en)
AR (1) AR026037A1 (en)
AU (1) AU7663100A (en)
CO (1) CO5261507A1 (en)
DE (1) DE19949209A1 (en)
WO (1) WO2001027080A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
EP1458713B1 (en) 2001-12-27 2005-08-24 Theravance, Inc. Indolinone derivatives useful as protein kinase inhibitors
US7514468B2 (en) 2002-07-23 2009-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions
US7169936B2 (en) 2002-07-23 2007-01-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments
DE10233500A1 (en) * 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z- [1- (4- (N - ((4-methyl-piperazin-1-yl) -methylcarbonyl) -N-methyl-amino) -anilino) -1-phenyl-methylene] -6-methoxycarbonyl- 2-indolinone monoethanesulfonate and its use as a medicament
US20040204458A1 (en) 2002-08-16 2004-10-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of Lck inhibitors for treatment of immunologic diseases
DE10237423A1 (en) * 2002-08-16 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treating immunological (or related) diseases, e.g. inflammatory bowel disease, rheumatoid arthritis or psoriasis, comprises administration of 3-methylene-2-indolinone derivative or quinazoline compound
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
US20050043233A1 (en) 2003-04-29 2005-02-24 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
DE102004012070A1 (en) * 2004-03-12 2005-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New cycloalkyl-containing 5-acylindolinones, their preparation and their use as medicaments
DE102004012068A1 (en) * 2004-03-12 2005-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg New alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceuticals
PE20060777A1 (en) 2004-12-24 2006-10-06 Boehringer Ingelheim Int INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
CA2646638A1 (en) * 2006-04-24 2007-11-01 Boehringer Ingelheim International Gmbh 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
AU2019352075B2 (en) * 2018-10-05 2022-07-21 Ichnos Sciences S.A. Indolinone compounds for use as MAP4K1 inhibitors
CN111285872B (en) * 2018-12-06 2022-05-17 北京志健金瑞生物医药科技有限公司 Indole-2-ketone derivative and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476307A (en) * 1982-09-20 1984-10-09 Pfizer Inc. Heteroylidene indolone compounds
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
DE19815020A1 (en) * 1998-04-03 1999-10-07 Boehringer Ingelheim Pharma New substituted indolinones, their production and their use as medicines

Also Published As

Publication number Publication date
WO2001027080A2 (en) 2001-04-19
DE19949209A1 (en) 2001-04-19
WO2001027080A3 (en) 2001-11-22
EP1224169A2 (en) 2002-07-24
CO5261507A1 (en) 2003-03-31
AR026037A1 (en) 2002-12-26

Similar Documents

Publication Publication Date Title
AU763356C (en) Fused-ring compounds and use thereof as drugs
AU7663100A (en) Production of 5-substituted indolinones and use thereof as medicaments
AU763094C (en) Benzimidazoles, production thereof and use thereof as medicaments
HUP0203190A3 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
AU3813499A (en) The use of dihydropyrimidines as medicaments, and novel substances
AU3364101A (en) Substituted piperazine derivatives, production thereof and use thereof as medicaments
EP1006110B8 (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
AU4949800A (en) 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
AU782631C (en) Novel heterocyclic compounds and salts thereof and medicinal use of the same
AU2177001A (en) Use of indirubine derivatives for making medicines
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
AU2001289758A1 (en) Novel indole derivatives and their use as medicaments
SI1268522T1 (en) Novel lhrh-antagonists, production and use thereof as medicament
HK1058201A1 (en) Novel indole derivatives and their use as medicaments
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
AU3553400A (en) Use and production of polypropylene
AU2001297611A1 (en) Pharmaceutical uses and synthesis of diketopiperazines
AU5416000A (en) Sulfonamide substituted benzylamine derivatives and their use as medicaments
AU2001260110A1 (en) Novel LHRH-antagonists, Production and Use Thereof as Medicament
AU2002308889A1 (en) Novel heterocyclic compound and medicinal use thereof
AU2432001A (en) Treatment of mental conditions including depression
AU5842300A (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
AU5086799A (en) Personal hygiene tablet composition
AU6294700A (en) Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase